Seminars in Nuclear Medicine
Volume 33, Issue 4 , Pages 246-258 , October 2003

Imaging in the evaluation of the patient with suspected acute coronary syndrome

  • Michael C Kontos

      Affiliations

    • Virginia Commonwealth University, VCU Medical Center, Medical College of Virginia Hospitals, Richmond, VA, USA
    • ,
  • James L Tatum

      Affiliations

    • Virginia Commonwealth University, VCU Medical Center, Medical College of Virginia Hospitals, Richmond, VA, USA
    • Corresponding Author InformationAddress reprint requests to James L. Tatum, MD, Virginia Commonwealth University, VCU Medical Center, 1101 East Marshall St., PO Box 980470, Richmond, VA 23298-0470, USA

References 

  1. Burt CW. Summary statistics for acute cardiac ischemia and chest pain visits to United States EDs, 1995–1996. Am J Emerg Med. 1999;17:552–559
  2. Lee TH, Rouan GW, Weisberg MC, et al.  Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol. 1987;60:219–224
  3. Pope JH, Aufderheide TP, Ruthazer R, et al.  Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 2000;342:1163–1170
  4. Faroghi A, Kontos MC, Jesse RL, et al.  Are cardiac risk factors predictive in low risk emergency department chest pain patients who have chest pain?. J Am Coll Cardiol. 2000;35:379A
  5. Lee TH, Goldman L. Evaluation of the patient with acute chest pain. N Engl J Med. 2000;342:1187–1195
  6. Wackers FJ, Lie KI, Liem KL, et al.  Potential value of thallium-201 scintigraphy as a means of selecting patients for the coronary care unit. Br Heart J. 1979;41:111–117
  7. van der Wieken LR, Kan G, Belfer AJ, et al.  Thallium-201 scanning to decide CCU admission in patients with non-diagnostic electrocardiograms. Int J Cardiol. 1983;4:285–299
  8. Mace SE. Thallium myocardial scanning in the emergency department evaluation of chest pain. Am J Emerg Med. 1989;7:321–328
  9. Henneman PL, Mena IG, Rothstein RJ, et al.  Evaluation of patients with chest pain and nondiagnostic ECG using thallium-201 myocardial planar imaging and technetium-99m first-pass radionuclide angiography in the emergency department. Ann Emerg Med. 1992;21:545–550
  10. Okada RD, Glover D, Gaffney T, et al.  Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation. 1988;77:491–498
  11. Mannting F, Morgan-Mannting MG. Gated SPECT with technetium-99m-sestamibi for assessment of myocardial perfusion abnormalities. J Nucl Med. 1993;34:601–608
  12. DePuey EG, Rozanski A. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med. 1995;36:952–955
  13. Nicholson CS, Tatum JL, Jesse RL, et al.  The value of gated tomographic Tc-99m-sestamibi perfusion imaging in acute ischemic syndromes. J Nucl Cardiol. 1995;2:S57
  14. Bilodeau L, Theroux P, Gregoire J, et al.  Technetium-99m sestamibi tomography in patients with spontaneous chest pain (Correlations with clinical, electrocardiographic and angiographic findings). J Am Coll Cardiol. 1991;18:1684–1691
  15. Hilton TC, Thompson RC, Williams HJ, et al.  Technetium-99m sestamibi myocardial perfusion imaging in the emergency room evaluation of chest pain. J Am Coll Cardiol. 1994;23:1016–1022
  16. Kontos MC, Jesse RL, Schmidt KL, et al.  Value of acute rest sestamibi perfusion imaging for evaluation of patients admitted to the emergency department with chest pain. J Am Coll Cardiol. 1997;30:976–982
  17. Heller GV, Stowers SA, Hendel RC, et al.  Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms. J Am Coll Cardiol. 1998;31:1011–1017
  18. Varetto T, Cantalupi D, Altieri A, et al.  Emergency room technetium-99m sestamibi imaging to rule out acute myocardial ischemic events in patients with nondiagnostic electrocardiograms. J Am Coll Cardiol. 1993;22:1804–1808
  19. Tatum JL, Jesse RL, Kontos MC, et al.  Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med. 1997;29:116–125
  20. Kontos MC, Jesse RL, Anderson FP, et al.  Comparison of myocardial perfusion imaging and cardiac troponin I in patients admitted to the emergency department with chest pain. Circulation. 1999;99:2073–2078
  21. Kontos MC, Kurdziel K, McQueen R, et al.  Comparison of 2-dimensional echocardiography and myocardial perfusion imaging for diagnosing myocardial infarction in emergency department patients. Am Heart J. 2002;143:659–667
  22. Lee KL, Woodlief LH, Topol EJ, et al.  Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41, 021 patients. GUSTO-I Investigators. Circulation. 1995;91:1659–1668
  23. Fioretti P, Sclavo M, Brower RW, et al.  Prognosis of patients with different peak serum creatine kinase levels after first myocardial infarction. Eur Heart J. 1985;6:473–478
  24. White HD, Norris RM, Brown MA, et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44–51
  25. Sabia P, Afrookteh A, Touchstone DA, et al.  Value of regional wall motion abnormality in the emergency room diagnosis of acute myocardial infarction. A prospective study using two-dimensional echocardiography. Circulation. 1991;84:I85–I92
  26. Reimer KA, Jennings RB, Cobb FR, et al.  Animal models for protecting ischemic myocardium: Results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models. Circ Res. 1985;56:651–665
  27. Sinusas AJ, Trautman KA, Bergin JD, et al.  Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Circulation. 1990;82:1424–1437
  28. Verani MS, Jeroudi MO, Mahmarian JJ, et al.  Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol. 1988;12:1573–1581
  29. De Coster PM, Wijns W, Cauwe F, et al.  Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction. Circulation. 1990;82:2152–2162
  30. Christian TF, Behrenbeck T, Gersh BJ, et al.  Relation of left ventricular volume and function over one year after acute myocardial infarction to infarct size determined by technetium-99m sestamibi. Am J Cardiol. 1991;68:21–26
  31. Christian TF, Behrenbeck T, Pellikka PA, et al.  Mismatch of left ventricular function and infarct size demonstrated by technetium-99m isonitrile imaging after reperfusion therapy for acute myocardial infarction (identification of myocardial stunning and hyperkinesia). J Am Coll Cardiol. 1990;16:1632–1638
  32. Behrenbeck T, Pellikka PA, Huber KC, et al.  Primary angioplasty in myocardial infarction (assessment of improved myocardial perfusion with technetium-99m isonitrile). J Am Coll Cardiol. 1991;17:365–372
  33. Kontos MC, Kurdziel KA, Ornato JP, et al.  A nonischemic electrocardiogram does not always predict a small myocardial infarction (Results with acute myocardial perfusion imaging). Am Heart J. 2001;141:360–366
  34. Hilton TC, Fulmer H, Abuan T, et al.  Ninety-day follow-up of patients in the emergency department with chest pain who undergo initial single-photon emission computed tomographic perfusion scintigraphy with technetium 99m-labeled sestamibi. J Nucl Cardiol. 1996;3:308–311
  35. O’Connor MK, Hammell T, Gibbons RJ. In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium 99m (sestamibi). Eur J Nucl Med. 1990;17:69–76
  36. Duca MD, Giri S, Wu AH, et al.  Comparison of acute rest myocardial perfusion imaging and serum markers of myocardial injury in patients with chest pain syndromes. J Nucl Cardiol. 1999;6:570–576
  37. Kontos MC, Fratkin MJ, Jesse RL, et al.  Rest myocardial perfusion imaging results in patients with troponin I elevations. J Am Coll Cardiol. 2002;39:332A
  38. de Winter RJ, Koster RW, Sturk A, et al.  Value of myoglobin, troponin T, and CK-MB mass in ruling out an acute myocardial infarction in the emergency room. Circulation. 1995;92:3401–3407
  39. Emre A, Ersek B, Gursurer M, et al.  Angiographic and scintigraphic (perfusion and electrocardiogram-gated SPECT) correlates of clinical presentation in unstable angina. Clin Cardiol. 2000;23:495–500
  40. Topol EJ, Weiss JL, Brinker JA, et al.  Regional wall motion improvement after coronary thrombolysis with recombinant tissue plasminogen activator (Importance of coronary angioplasty). J Am Coll Cardiol. 1985;6:426–433
  41. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial (Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest). Circulation. 1993;87:38–52
  42. Heeschen C, van den Brand MJ, Hamm CW, et al.  Angiographic findings in patients with refractory unstable angina according to troponin T status. Circulation. 1999;100:1509–1514
  43. Zhao X-Q, Theroux P, Snapinn SM, et al.  Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with Tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trail (platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). Circulation. 1999;100:1609–1615
  44. Koch KC, vom Dahl J, Kleinhans E, et al.  Influence of a platelet GP IIb/IIIa receptor antagonist on myocardial hypoperfusion during rotational atherectomy as assessed by myocardial Tc-99m sestamibi scintigraphy. J Am Coll Cardiol. 1999;33:998–1004
  45. Fram DB, Azar RR, Ahlberg AW, et al.  Duration of abnormal SPECT myocardial perfusion imaging following resolution of acute ischemia (An angioplasty model). J Am Coll Cardiol. 2003;41:452–459
  46. Weissman IA, Dickinson CZ, Dworkin HJ, et al.  Cost-effectiveness of myocardial perfusion imaging with SPECT in the emergency department evaluation of patients with unexplained chest pain. Radiology. 1996;199:353–357
  47. Radensky PW, Hilton TC, Fulmer H, et al.  Potential cost effectiveness of initial myocardial perfusion imaging for assessment of emergency department patients with chest pain. Am J Cardiol. 1997;79:595–599
  48. Kontos MC, Schmidt KL, McCue M, et al.  A comprehensive strategy for the evaluation and triage of the chest pain patient (A cost comparison study). J Nucl Cardiol. 2003;10:284–290
  49. Udelson JE, Beshansky JR, Ballin DS, et al.  Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia (A randomized controlled trial). JAMA. 2002;288:2693–2700
  50. McGuire DK, Hudson MP, East MA, et al.  Highlights from the American Heart Association 72nd Scientific Sessions (November 6 to 10, 1999). Am Heart J. 2000;139:359–370
  51. Wackers FJ, Brown KA, Heller GV, et al.  American Society of Nuclear Cardiology position statement on radionuclide imaging in patients with suspected acute ischemic syndromes in the emergency department or chest pain center. J Nucl Cardiol. 2002;9:246–250
  52. Fesmire FM, Hughes AD, Stout PK, et al.  Selective dual nuclear scanning in low-risk patients with chest pain to reliably identify and exclude acute coronary syndromes. Ann Emerg Med. 2001;38:207–215
  53. Schmermund A, Denktas AE, Rumberger JA, et al.  Independent and incremental value of coronary artery calcium for predicting the extent of angiographic coronary artery disease (Comparison with cardiac risk factors and radionuclide perfusion imaging). J Am Coll Cardiol. 1999;34:777–786
  54. Budoff MJ, Diamond GA, Raggi P, et al.  Continuous probabilistic prediction of angiographically significant coronary artery disease using electron beam tomography. Circulation. 2002;105:1791–1796
  55. O’Rourke RA, Brundage BH, Froelicher VF, et al.  American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation. 2000;102:126–140
  56. Nallamothu BK, Saint S, Bielak LF, et al.  Electron-beam computed tomography in the diagnosis of coronary artery disease (A meta-analysis). Arch Intern Med. 2001;161:833–838
  57. Schmermund A, Baumgart D, Sack S, et al.  Assessment of coronary calcification by electron-beam computed tomography in symptomatic patients with normal, abnormal or equivocal exercise stress test. Eur Heart J. 2000;21:1674–1682
  58. Shavelle DM, Budoff MJ, Lamont DH, et al.  Exercise testing and electron beam computed tomography in the evaluation of coronary artery disease. J Am Coll Cardiol. 2000;36:32–38
  59. He ZX, Hedrick TD, Pratt CM, et al.  Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia. Circulation. 2000;101:244–251
  60. Haberl R, Becker A, Leber A, et al.  Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease (Results of 1, 764 patients). J Am Coll Cardiol. 2001;37:451–457
  61. Raggi P, Callister TQ, Cooil B, et al.  Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation. 2000;101:850–855
  62. Arad Y, Spadaro LA, Goodman K, et al.  In: Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173. 1996;p. 1951–1953 (asymptomatic subjects. Circulation 93)
  63. Broderick LS, Shemesh J, Wilensky RL, et al.  Measurement of coronary artery calcium with dual-slice helical CT compared with coronary angiography (Evaluation of CT scoring methods, interobserver variations, and reproducibility). AJR Am J Roentgenol. 1996;167:439–444
  64. Shemesh J, Apter S, Rozenman J, et al.  Calcification of coronary arteries (Detection and quantification with double-helix CT). Radiology. 1995;197:779–783
  65. Shemesh J, Tenenbaum A, Fisman EZ, et al.  Absence of coronary calcification on double-helical CT scans (Predictor of angiographically normal coronary arteries in elderly women?). Radiology. 1996;199:665–668
  66. Carr JJ, Crouse JR, Goff DC, et al.  Evaluation of subsecond gated helical CT for quantification of coronary artery calcium and comparison with electron beam CT. AJR Am J Roentgenol. 2000;174:915–921
  67. Becker CR, Jakobs TF, Aydemir S, et al.  Helical and single-slice conventional CT versus electron beam CT for the quantification of coronary artery calcification. AJR Am J Roentgenol. 2000;174:543–547
  68. Elad Y, Detrano RC. Computed tomography of the heart. In:  Topol EJ editors. Textbook of Cardiovascular Medicine Updates 4(4). Cedar Knolls, NJ: Lippincott Williams & Wilkins Healthcare; 2001;
  69. Laudon DA, Vukov LF, Breen JF, et al.  Use of electron-beam computed tomography in the evaluation of chest pain patients in the emergency department. Ann Emerg Med. 1999;33:15–21
  70. McLaughlin VV, Balogh T, Rich S. Utility of electron beam computed tomography to stratify patients presenting to the emergency room with chest pain. Am J Cardiol. 1999;84:327–328
  71. Mitchell TL, Pippin JJ, Devers SM, et al.  Age- and sex-based nomograms from coronary artery calcium scores as determined by electron beam computed tomography. Am J Cardiol. 2001;87:453–456
  72. Hundley WG, Hamilton CA, Thomas MS, et al.  Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation. 1999;100:1697–1702
  73. Hundley WG, Morgan TM, Neagle CM, et al.  Magnetic resonance imaging determination of cardiac prognosis. Circulation. 2002;106:2328–2333
  74. Kwong RY, Schussheim AE, Rekhraj S, et al.  Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation. 2003;107:531–537
  75. Kramer CM. Magnetic resonance imaging to identify the high-risk plaque. Am J Cardiol. 2002;90:15L–17L
  76. Fayad ZA, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res. 2001;89:305–316
  77. Choudhury RP, Fuster V, Badimon JJ, et al.  MRI and characterization of atherosclerotic plaque (Emerging applications and molecular imaging). Arterioscler Thromb Vasc Biol. 2002;22:1065–1074
  78. Botnar RM, Stuber M, Kissinger KV, et al.  Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation. 2000;102:2582–2587
  79. Guazzi MD, Bussotti M, Grancini L, et al.  Evidence of multifocal activity of coronary disease in patients with acute myocardial infarction. Circulation. 1997;96:1145–1151
  80. Rioufol G, Finet G, Ginon I, et al.  Multiple atherosclerotic plaque rupture in acute coronary syndrome (A three-vessel intravascular ultrasound study). Circulation. 2002;106:804–808
  81. Litovsky S, Madjid M, Zarrabi A, et al.  Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo (Enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma). Circulation. 2003;107:1545–1549
  82. Schmitz SA, Coupland SE, Gust R, et al.  Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Invest Radiol. 2000;35:460–471
  83. Schmitz SA, Taupitz M, Wagner S, et al.  Iron-oxide-enhanced magnetic resonance imaging of atherosclerotic plaques (Postmortem analysis of accuracy, inter-observer agreement, and pitfalls). Invest Radiol. 2002;37:405–411
  84. Ruehm SG, Corot C, Vogt P, et al.  Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation. 2001;103:415–422
  85. Schmitz SA, Taupitz M, Wagner S, et al.  Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J Magn Reson Imaging. 2001;14:355–361
  86. Kooi ME, Cappendijk VC, Cleutjens KB, et al.  Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation. 2003;107:2453–2458
  87. Herborn CU, Lauenstein TC, Vogt FM, et al.  MR imaging of athersclerotic plaque with new Ultrasmall Particles of Iron Oxide (7228) compared to Sinerem in hyperlipidemic rabbits. Proc Int Soc Magn Res Med. 2002;10:

PII: S0001-2998(03)00030-8

doi: 10.1016/S0001-2998(03)00030-8

Seminars in Nuclear Medicine
Volume 33, Issue 4 , Pages 246-258 , October 2003

Article Tools

* Image Usage & Resolution